ERBB2 and breast carcinoma: Predicting pCR with 18F-FDG PET/CT in breast cancer has been intensively studied, and, currently, the most powerful predictor from this modality is using the change in tumor SUVmax after 1 or 2 cycles of NAC in HER2-positive and TN tumors [34,35,36,37].